| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8343706 | Molecular Genetics and Metabolism | 2017 | 43 Pages |
Abstract
This review discusses expert opinions on key issues and considerations for effective neurocognitive testing in MPS patients. In addition, it describes the neurocognitive assessment tools that have been used in clinical practice for these patients. The content of this review is based on existing literature and information from a meeting of international experts with extensive experience in managing and treating MPS disorders.
Keywords
BASCVineland Adaptive Behavior ScalesBayley Scales of Infant and Toddler DevelopmentMPS IHMucopolysaccharidosesGAGsWISCISPORAEqWPPSIKaufman Assessment Battery for ChildrenMDIHAQDASBSIDCBCLASQCognition disordersintelligence quotientLysosomal storage diseasesIntelligence testsCNSPsychologyVABSHurler syndromecentral nervous systemMental Developmental IndexDevelopmental quotientMPsHealth Assessment QuestionnaireAges and Stages QuestionnaireWechsler Preschool and Primary Scale of IntelligenceChild Behavior ChecklistGlycosaminoglycans
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Elsa G. Shapiro, Maria L. Escolar, Kathleen A. Delaney, John J. Mitchell,